NDC 0121-2134-06 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0121-2134
- Requested NDC
- 0121-2134-06
- Package NDCs from labels
- 0121-2134-06, 0121-2134-40
- Manufacturer
- PAI Holdings, LLC dba PAI Pharma
- Effective date
- 2025-05-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - PAI Holdings, LLC dba PAI Pharma | PAI Holdings, LLC dba PAI Pharma | 2025-05-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-2134-06 | Gabapentin | 6 mL in 1 CUP, UNIT-DOSE | SOLUTION | 6 | 3 | |
| 0121-2134-40 | Gabapentin | 10 in 1 TRAY | SOLUTION | 10 | 3 | |
| 0121-2134-40 | Gabapentin | 4 in 1 CASE | SOLUTION | 4 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-2134-06 | ML - Milliliter | 0121-2134 | 9842fb1d-ee54-4775-9545-c3bdf48aaea0 | 1 | 2025-07-08 |
| 0121-2134-40 | ML - Milliliter | 0121-2134 | 2910adc1-6b49-4885-b399-727df7115d8d | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 9b175f8d-7667-4bfe-8bb5-fd7441eed456 | 2026-07-08 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 4ddcdff5-8f1f-bff3-e063-6294a90a1195 | 2026-07-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Retaine CMC | CARBOXYMETHYLCELLULOSE SODIUM | OCuSOFT LLC | a3698c71-0c80-4246-be52-5e7d96f6c540 | 2026-07-06 | Warnings | K679OBS311 |
| Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) | NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) | Reedfresh Co., LTD | 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 | 2026-07-05 | Warnings | 059QF0KO0R |
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | dd7adad2-e2f5-4b43-90a4-522bce0be5b3 | 2026-07-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | f6ff265b-569b-4f5c-8fdb-00b7ad4aac7c | 2026-07-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Protective Industrial Products, Inc. | 558e5926-9027-d3f6-e063-6294a90ab121 | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 2000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a1d07e-0006-0c75-e063-6394a90a7acc | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-07-02 | Warnings | 059QF0KO0R |
| Sterile Eyesaline Eyewash | STERILE EYESALINE EYEWASH | Protective Industrial Products, Inc. | 55a290e8-8310-8be4-e063-6394a90abdce | 2026-07-02 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Protective Industrial Products, Inc. | 55a261c2-725d-6765-e063-6294a90a3260 | 2026-07-02 | Warnings | 059QF0KO0R |
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | 059QF0KO0R |
| gabapentin | GABAPENTIN | Sun Pharmaceutical Industries, Inc. | c9a05f0c-b5f0-422c-9d67-6d0efc921a74 | 2026-07-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Strides Pharma Science Limited | 43b67ae3-ac6f-48f5-8788-9ead08376864 | 2026-07-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 9d401e54-d4f5-43ba-b898-dd08fc3c7bfa | 2026-07-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gralise | GABAPENTIN | Almatica Pharma LLC | 466273b1-c9fc-3930-c94b-aa11394d5140 | 2026-06-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | 14d61caa-17ce-4fa2-90fb-1470f3864be8 | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 2bc65375-77b8-1e50-e063-6294a90acf8f | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | ba4d863d-be38-8cf5-e053-2995a90a69fb | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | c85ae572-9893-629e-e053-2995a90a23fc | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.